Chun-Chieh Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chun-Chieh Huang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Chen-Shuan Chung
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan
2 shared publications - Chen-Yen Lu
From the Division of Gastroenterology and Hepatology, Department of Internal Medicine (C.Y.L., P.C.T., K.C.C., T.H.L., C.K.L., C.S.C.), and Department of Radiology (C.C.H., Y.M.T.), Far Eastern Memorial Hospital, 21 Nan-Ya South Rd, Section 2, Banciao District, New Taipei City, Taiwan 22060; and College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan (C.S.C.).
2 shared publications - Cheng-Kuan Lin
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan
2 shared publications Kuan-Chih Chen
From the Division of Gastroenterology and Hepatology, Department of Internal Medicine (C.Y.L., P.C.T., K.C.C., T.H.L., C.K.L., C.S.C.), and Department of Radiology (C.C.H., Y.M.T.), Far Eastern Memorial Hospital, 21 Nan-Ya South Rd, Section 2, Banciao District, New Taipei City, Taiwan 22060; and College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan (C.S.C.).
2 shared publications- Kuo-Shyang Jeng
Division of General Surgery, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan
2 shared publications - Po-Chun Tseng
From the Division of Gastroenterology and Hepatology, Department of Internal Medicine (C.Y.L., P.C.T., K.C.C., T.H.L., C.K.L., C.S.C.), and Department of Radiology (C.C.H., Y.M.T.), Far Eastern Memorial Hospital, 21 Nan-Ya South Rd, Section 2, Banciao District, New Taipei City, Taiwan 22060; and College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan (C.S.C.).
2 shared publications
Latest Publications
- Open Access
- 1 March 2025
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 28 (3) , 174-176
Idiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
- 1 March 2025
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 28 (3) , 174-176
Open AccessIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
- Open Access
- 22 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 32
Rare Condition of Aberrant Arterial Supply to a Normal Lung: A Cases Series and Literature Review
Herein, we describe an aberrant artery to a normal lung, focusing on its classification, embryological hypotheses, diagnostic methods, and treatment modalities. We present three cases of aberrant arterial supply to a normal lung in various age groups (51 years, 5 months, and 29 years). The cases presented symptoms ranging from hemoptysis to respiratory distress. Successful transarterial embolization was performed in the 5-month-old infant. In addition, we collected case reports published from 1962 to the present from the literature to compare the trends in management and variations in manifestations.
- 22 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 32
Open AccessRare Condition of Aberrant Arterial Supply to a Normal Lung: A Cases Series and Literature Review
Herein, we describe an aberrant artery to a normal lung, focusing on its classification, embryological hypotheses, diagnostic methods, and treatment modalities. We present three cases of aberrant arterial supply to a normal lung in various age groups (51 years, 5 months, and 29 years). The cases presented symptoms ranging from hemoptysis to respiratory distress. Successful transarterial embolization was performed in the 5-month-old infant. In addition, we collected case reports published from 1962 to the present from the literature to compare the trends in management and variations in manifestations.
- Open Access
- 11 February 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (7) , 2802-2803
Indocyanine green staining via hyperselective portal vein angiographic approach for laparoscopic S8 anatomical subsegmentectomy
- 11 February 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (7) , 2802-2803
Open AccessIndocyanine green staining via hyperselective portal vein angiographic approach for laparoscopic S8 anatomical subsegmentectomy
- Open Access
MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis
Obesity is closely linked to metabolic diseases, particularly non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD), ultimately leading to hepatocellular carcinoma (HCC). However, the molecular mechanisms of NASH-associated HCC (NAHCC) remain elusive. To explore the impact of Max dimerization protein 3 (MXD3), a transcription factor that regulates several cellular functions in disorders associated with metabolic diseases, we conditionally expressed Mxd3 proteins using Tet-on mxd3 transgenic zebrafish (MXs) with doxycycline (MXs + Dox) or without doxycycline (MXs − Dox) treatment. Overexpression of global MXD3 (gMX) or hepatic Mxd3 (hMX) was associated with obesity-related NAFLD pathophysiology in gMX + Dox, and liver fibrosis and HCC in hMX + Dox. Oil Red O (ORO)-stained signals were seen in intravascular blood vessels and liver buds of larval gMX + Dox, indicating that Mxd3 functionally promotes lipogenesis. The gMX + Dox-treated young adults exhibited an increase in body weight and visceral fat accumulation. The hMX + Dox-treated young adults showed normal body characteristics but exhibited liver steatosis and NASH-like phenotypes. Subsequently, steatohepatitis, liver fibrosis, and NAHCC were found in 6-month-old gMX + Dox adults compared with gMX − Dox adults at the same stage. Overexpression of Mxd3 also enhanced AR expression accompanied by the increase of AR-signaling pathways resulting in hepatocarcinogenesis in males. Our results demonstrate that global actions of Mxd3 are central to the initiation of obesity in the gMX zebrafish through their effects on adipogenesis and that MXD3 could serve as a therapeutic target for obesity-associated liver diseases.
Open AccessMXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis
Obesity is closely linked to metabolic diseases, particularly non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD), ultimately leading to hepatocellular carcinoma (HCC). However, the molecular mechanisms of NASH-associated HCC (NAHCC) remain elusive. To explore the impact of Max dimerization protein 3 (MXD3), a transcription factor that regulates several cellular functions in disorders associated with metabolic diseases, we conditionally expressed Mxd3 proteins using Tet-on mxd3 transgenic zebrafish (MXs) with doxycycline (MXs + Dox) or without doxycycline (MXs − Dox) treatment. Overexpression of global MXD3 (gMX) or hepatic Mxd3 (hMX) was associated with obesity-related NAFLD pathophysiology in gMX + Dox, and liver fibrosis and HCC in hMX + Dox. Oil Red O (ORO)-stained signals were seen in intravascular blood vessels and liver buds of larval gMX + Dox, indicating that Mxd3 functionally promotes lipogenesis. The gMX + Dox-treated young adults exhibited an increase in body weight and visceral fat accumulation. The hMX + Dox-treated young adults showed normal body characteristics but exhibited liver steatosis and NASH-like phenotypes. Subsequently, steatohepatitis, liver fibrosis, and NAHCC were found in 6-month-old gMX + Dox adults compared with gMX − Dox adults at the same stage. Overexpression of Mxd3 also enhanced AR expression accompanied by the increase of AR-signaling pathways resulting in hepatocarcinogenesis in males. Our results demonstrate that global actions of Mxd3 are central to the initiation of obesity in the gMX zebrafish through their effects on adipogenesis and that MXD3 could serve as a therapeutic target for obesity-associated liver diseases.
- 1 December 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 301 (3) , 735-740
Case 296: Phlebosclerotic Colitis
History A 55-year-old woman without systemic underlying disease, such as diabetes mellitus, inflammatory bowel disease, autoimmune disease, or chronic kidney disease, presented with generalized dul...
- 1 December 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 301 (3) , 735-740
Case 296: Phlebosclerotic Colitis
History A 55-year-old woman without systemic underlying disease, such as diabetes mellitus, inflammatory bowel disease, autoimmune disease, or chronic kidney disease, presented with generalized dul...
- 1 August 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 300 (2) , 481-483
Case 296
History A 55-year-old woman without systemic underlying disease, such as diabetes mellitus, inflammatory bowel disease, autoimmune disease, or chronic kidney disease, presented with generalized dull abdominal pain of 1-week duration. She had ingested herbal medicine for physical conditioning for several years. Laboratory findings, including biochemistry, electrolyte levels, and complete blood count, were all within normal limits, except for elevated serum C-reactive protein level (7.719 mg/dL; normal range,<1 mg/dL). The patient underwent initial evaluation with conventional abdominal radiography (Fig 1). She underwent subsequent evaluation with noncontrast CT of the abdomen (Figs 2, 3) and colonoscopy (Fig 4).
- 1 August 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 300 (2) , 481-483
Case 296
History A 55-year-old woman without systemic underlying disease, such as diabetes mellitus, inflammatory bowel disease, autoimmune disease, or chronic kidney disease, presented with generalized dull abdominal pain of 1-week duration. She had ingested herbal medicine for physical conditioning for several years. Laboratory findings, including biochemistry, electrolyte levels, and complete blood count, were all within normal limits, except for elevated serum C-reactive protein level (7.719 mg/dL; normal range,<1 mg/dL). The patient underwent initial evaluation with conventional abdominal radiography (Fig 1). She underwent subsequent evaluation with noncontrast CT of the abdomen (Figs 2, 3) and colonoscopy (Fig 4).
- 1 May 2017
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101 (5S-3) , S20
Novel Use of Percutaneous Thrombosuction for Hepatic Vein Thrombosis of the Liver Graft after Liver Transplantation
- 1 May 2017
- Published by Wolters Kluwer Health in Transplantation
- Vol. 101 (5S-3) , S20
Novel Use of Percutaneous Thrombosuction for Hepatic Vein Thrombosis of the Liver Graft after Liver Transplantation
- 1 May 2016
- Published by Elsevier in Transplantation Proceedings
- Vol. 48 (4) , 1149-1155
Early Detection of a Hepatic Artery Pseudoaneurysm After Liver Transplantation Is the Determinant of Survival
- 1 May 2016
- Published by Elsevier in Transplantation Proceedings
- Vol. 48 (4) , 1149-1155
Early Detection of a Hepatic Artery Pseudoaneurysm After Liver Transplantation Is the Determinant of Survival